CAR T Cells Redirected to CD44v6 Control Tumor Growth in Lung and Ovary Adenocarcinoma Bearing Mice

The main challenge of adoptive therapy with Chimeric Antigen Receptor modified T cells (CAR T) is the application to the field of solid tumors, where the identification of a proper antigen has emerged as one of the major drawbacks to CAR T cell treatment success. CD44 is a glycoprotein involved in c...

Descripción completa

Detalles Bibliográficos
Autores principales: Porcellini, Simona, Asperti, Claudia, Corna, Stefano, Cicoria, Eleonora, Valtolina, Veronica, Stornaiuolo, Anna, Valentinis, Barbara, Bordignon, Claudio, Traversari, Catia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7010926/
https://www.ncbi.nlm.nih.gov/pubmed/32117253
http://dx.doi.org/10.3389/fimmu.2020.00099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7010926/
https://www.ncbi.nlm.nih.gov/pubmed/32117253
http://dx.doi.org/10.3389/fimmu.2020.00099

Ejemplares similares